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site in response to various agonists. Moreover, the patient presented a mode-
rate immune de¿ ciency indicating a more diffuse defect similar to a type III 
Leukocyte Adhesion De¿ ciency variant (LADIII variant). This pathology was 
recently associated to mutations in the FERMT3 gene that is responsible for 
the abnormal expression of the kindlin-3 protein. It is strongly involved in the 
integrin activation process. Here we report the ¿ rst French case of LAD-III 
caused by a newly discovered mutation in the FERMT3 gene. The kindlin-3 
de¿ cient leukocytes are able to easily form initial bounds in response to a 
chemotactic agent or to a phorbol ester. However, the patient’s neutrophils 
and lymphocytes displayed a reduced ability to strengthen preformed bounds 
compared to leukocytes isolated from his parents and healthy volunteers. 
Furthermore, the integrin dependent and independent spreading ability of the 
patient’s T lymphocytes was markedly reduced.
Conclusion: The effects of a kindlin-3 de¿ ciency on integrin function are 
mainly dependent on the cell type studied and on the stimulus causing their 
activation. Our results also highlight the possible implication of kindlin-3 in 
integrins independent mechanisms.
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In¿ ltration of leukocytes in ischemic areas is a hallmark of myocardial infarc-
tion (MI), and overwhelming inÀ ammation promotes adverse ventricular remode-
ling. Recruitment of leukocytes following MI partially depends on inÀ ammatory 
CC-chemokines. We hypothesized that the chemokine decoy receptor D6, that 
speci¿ cally recognizes and scavenges inÀ ammatory CC-chemokines, might 
prevent excessive inÀ ammation and adverse remodelling after MI. In a murine 
model of MI, D6 expression in the ischemic left ventricle raised by 250% at 5 
and 7 days after the onset of ischemia (p<0.001). Protein levels of CCL2 and 
CCL3, two D6 targets, were increased in the ischemic myocardium, peaking 
at day 3 (p<0.001 vs baseline), and progressively returning to basal levels 
between days 5 and 7. In¿ ltration of CD45+ leukocytes in the ischemic myo-
cardium of D6-/- mice was increased by 180%  (p<0.05) and 200%  (p<0.05) at 
5 and 7 days post-MI, respectively. Interestingly, we noted a selective increase 
of Ly6Chi monocytes (210% at 5 days, p<0.05 and 170% at 7 days, p<0.05) 
and Neutrophils (160% at 5 days, p<0.05 and 500% at 7 days, p<0.01) levels 
in D6-/- ischemic hearts. D6-/- mice were cardiac rupture-prone and displayed 
decreased post-MI survival (p=0.02 vs WT mice).  14 days after myocardial 
infarction, D6-/- mice showed features of adverse ventricular remodelling: end-
diastolic and end-systolic endocardial volumes were increased by 40% and 
50%, respectively (p<0.01), endocardial ejection fraction was reduced by 50% 
(p<0.05) and infarct size was increased by 30% (p<0.05). Leukocytes born D6 
had no effect, as WT mice lethally irradiated and reconstituted with D6-/- bone 
marrow derived cells showed normal post-MI inÀ ammation and remodelling. 
Altogether, these data demonstrate, for the ¿ rst time, that the chemokine decoy 
receptor D6 limits MI-associated inÀ ammation, and prevents adverse ventricular 
remodelling after MI.
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Atherosclerosis is an inÀ ammatory disease in which circulating mono-
cyte subsets in¿ ltrate the intima and contribute to plaque development. They 
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The MSRV (Multiple Sclerosis Associated Retro Virus) belongs to human 
endogenous retrovirus HERV-W family. An envelope protein originating from 
the MSRV was found in most patients with multiple sclerosis (MS). This 
protein (ENV-MS) has pro-inÀ ammatory properties on several immune cells 
and could therefore play a role in the MS pathogenesis by promoting the 
leukocyte diapedesis observed in the central nervous system of patients. Our 
study aims to analyze the effects of ENV-MS on the blood-brain barrier (BBB) 
at a molecular and functional level.
So far we have demonstrated that a recombinant MSRV envelope was 
able to strongly stimulate several inÀ ammatory parameters on a human BBB 
model. Indeed, ENV-MS induced overexpression of ICAM-1 in a dose- 
dependent manner and a strong dose-dependent production of the inÀ amma-
tory cytokines IL-6 and IL-8. Furthermore, we have shown that ENV-MS was 
recognized via the TLR4 receptor (Toll Like Receptor 4), a pattern recognition 
receptor present on the membrane of endothelial cells. At a functional level, 
we have also shown that the treatment with ENV-MS signi¿ cantly stimulated 
the adhesion of activated immune cells to a monolayer of endothelial cells.
These ¿ ndings support the hypothesis that MSRV could be involved in the 
pathogenesis of MS disease or at least in maintenance of inÀ ammatory condi-
tions thus fueling the auto-immune disorder.
Ongoing work, at functional level, is to measure the BBB model permeabi-
lity after treatment with ENV-MS using transwell assays. These experiments 
should allow us to demonstrate that ENV-MS induces an increase of transmi-
gration of immune cells across the monolayer.
Finally, we are currently developing animal models. These animals are 
transgenic mice expressing MSRV envelope with an inducible expression 
system. This model should allow us to study the proinÀ ammatory effects of 
MSRV in a model closer to physiopathological conditions.
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Introduction: In the present study we describe the case of a young patient 
from gipsy origin. He had to be hospitalized because of an important bleeding 
disorder mainly observable on skin and mucosa.
Results: Platelet functional study directed the diagnosis towards a 
Glanzmann thrombasthenia. Surprisingly, genetic analysis highlighted that the 
patient was heterozygous for the French gipsy mutation (1544+1G>A transi-
tion in the intron 15 of the ITGA2B gene) incompatible with the observed phe-
notype. Even though, the DIIbE3 integrin surface expression appeared to be 
normal, the patient’s platelets were unable to unmask the ¿ brinogen binding 
▼ ▼
01_corpus_ok.indd   3 26/04/2011   15:50:03
4 Archives of Cardiovascular Diseases Supplements (2011) 2, 1-91
© Elsevier Masson SAS. All rights reserved.
0226
Acute myocardial infarction and breast cancer: data from the RICO 
survey
Carole Richard (1), Yves Cottin (1), Luc Lorgis (1), Aurélie Gudjoncik (1), 
Patrick Arveux (2), Bruno Coudert (2), Claude Touzery (1), Catherine 
Vergely (3), Luc Rochette (3), Marianne Zeller [Orateur] (3)
(1) Department of Cardiology, University Hospital, Dijon, France – 
(2) Center Georges-François Leclerc, Center for Cancer of Burgundy, Dijon, 
France – (3) Laboratory of Experimental Cardiovascular Pharmacology 
and Pathophysiology, Faculties of Medicine and Pharmacy, Dijon, France
Objective: Breast cancer is the most frequent cancer in French women popu-
lation. Since few years its prognosis has been improved thanks to the screening 
and therapeutic progresses. Unfortunately, it is now well known that radiotherapy 
and chemotherapy can promote coronary events. However, to our knowledge, 
characteristics and management of acute myocardial infarction (AMI) in this 
population has not been determined yet that’s why we decide to focus on.
Patients and methods: 73 patients with breast cancer history were iden-
ti¿ ed among the 2087 women patients included in RICO (obseRvatoire des 
Infarctus de Côte d’Or) for AMI since 2001 to 2009. We matched up these 
73 patients with 5 patients with an AMI, with respect to age, and gender in 
order to compare their clinical, angiographic and biological characteristics.
Results: Median age of these populations was 74 (65-80) years. No signi-
¿ cant difference was found between these 2 populations considering cardio-
vascular risks. Type of MI (NSTEMI, STEMI) and its complications during 
the hospitalisation were not different between the 2 groups. Management 
and therapeutics begin during the acute phase seem not to be inÀ uenced by 
breast cancer history. However, we noticed that among biological parame-
ters, there were 2 surprising statistical signi¿ cant differences concerning CRP 
and CPK levels during AMI in favour of breast cancer population. Thus, CRP 
median level in breast cancer population was 1.00 mg/l (1.00–9.80) whereas 
it was equalled to 5.60 mg/l (2.80–13.60) in patients without history of breast 
cancer (p<0.001). Furthermore CPK median level was 310 UI/l (136–777) in 
breast cancer population, at the opposite the median level of this enzyme was 
501 UI/l (198-1324) in patients without past of breast cancer (p=0.022).
Conclusions: These results suggest that MI size evaluated by CPK plasma 
level is smaller in patients with MI and breast cancer history than patients 
unharmed of breast cancer. Perhaps, hormonal therapy such as aromatase inhi-
bitors and Tamoxifen take a part in the explanation of these results. 
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We aimed to evaluate the periodontal status in patients with acute myocar-
dial infarction (AMI) and to determine whether there was a speci¿ c pro¿ le 
according to age.
Methods: In 197 consecutive AMI patients the number of teeth, endo-
dontically treated teeth, periodontal screening index (PSI), clinical attachment 
level, and radiographic apical lesions were examined. Patients were classi¿ ed 
according to tertiles of age.
Results: The study demonstrated that patients with AMI exhibited an unfa-
vourable dental state of health. No relationship was found between C-reactive 
protein levels and periodontitis.
 differentiate into macrophages and produce inÀ ammatory molecules such as 
IL-1E that is obtained from pro-IL-1E selectively cleaved by multiproteic 
complexes named inÀ ammasomes. Our preliminary results established that 
NLRP3 inÀ ammasome is expressed in plaques of LDLR-/- mice fed a High 
Fat Diet (HFD). The aim of this study is to set up a human cell pattern using 
human monocytes from ATCC to study the modulation of NLRP3 inÀ amma-
some activity by different stimuli.
Immunocytochemistry using 3 different antibodies performed on aortic valves 
cryosections obtained from mice fed a HFD for 10 weeks con¿ rms the presence 
of NLRP3 marker into the plaques. We also evidenced labeled mononuclear cir-
culating cells suspected to be activated monocytes. We cultured and differenti-
ated human THP-1 monocytes using phorbol ester (TPA) at 20nM for 24 hours. 
Cells were then treated with LPS (10 and 100 ng/ml) for 6, 24 or 48 hours. 
Immunocytochemistry using the same antibodies demontrated an induction of 
NLRP3 expression at both LPS concentrations and at any times investigated. 
We measured the proinÀ ammatory response of THP-1 cells cultured in the des-
cribed differentiation conditions after 24 hours of LPS treatment through the 
release of IL-1E assessed by ELISA. Supernatants were harvested and cells col-
lected and lysed in RIPA buffer. ELISA is processed on supernatants and cell 
lysates. Whatever the concentrations of LPS, THP-1 produced IL-1E, which 
quantities are 10-fold higher in the supernatants than in the cells.
NLRP3 inÀ ammasome is expressed in THP-1 cells. Upon stimulation by 
LPS, NLRP3 is activated and able to process and secrete IL-1E. This assay 
will permit studying activators and inhibitors of NLRP3 and performing a 
screening of potential atherogenic and anti-atherogenic molecules.
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Background: After more than two decades of AIDS epidemic, the spectrum 
of HIV-associated disease has considerably evolved from infectious disease with 
improved survival, to cardiovascular diseases and particularly coronary diseases 
due to chronic inÀ ammation. As a consequence, myocardial infarctions are cur-
rently growing and few data are available on short-term prognosis in MI in HIV 
infected patients. The aim of this study was to examine the rate, characteristics 
and hospital case fatality of HIV-infected patients with MI.
Patients and methods: From the French nationwide hospital medical infor-
mation database, data from all the consecutive patients hospitalized in the 
1546 French hospital/clinics for myocardial infarction from 1st January 2005 
to 31st December 2009 were analyzed. Data were extracted with codes of the 
International Classi¿ cation of Diseases, tenth revision (ICD-10).
Results: Among the 677.305 patients included, the prevalence of HIV-
infected patients was 0.2% (1347). HIV patients were younger, and more fre-
quently male and smoker. By multivariate logistic regression analysis, age 
(OR=1.03), sex (OR=0.94), smoking (OR=0.70), hypertension (OR=0.67), dia-
betes (OR=0.91), dyslipidemia (OR=0.48), obesity (OR=0.86), atrial ¿ brilla-
tion (OR=0.85), PCI (OR=0.51), bypass (OR= 0.70) and STEMI (OR=4.22) 
are predicting factors for case fatality, while HIV infected patients were not 
associated with a worse prognosis (OR=1.03, p=0.802). However, in a sub-
group of HIV infected patients matched for age, sex and STEMI with non HIV 
infected (matching ratio: 1:2), hospital case fatality showed a trend toward an 
increased risk in HIV group (3.12 vs 4.31%, p=0.053).
Conclusion: In our retrospective large nationwide study, the hospital case 
fatality of HIV-infected could be increased when compared with non HIV 
infected patients. Further strati¿ ed analysis are needed in order to better cha-
racterize the management and speci¿ c outcomes of HIV-infected patients.
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Objective: High blood glucose (HBG) on admission is a major common 
metabolic disorder in patients with acute myocardial infarction (MI) and is 
associated with worse prognosis. However, only few data have examined its 
predictive performance over established risk score.
Patients and methods: From a French regional survey for acute MI, we 
analyzed the relationship between HBG, as defined by admission glycemia 
>11 mmol/L, and 1 year mortality in patients with acute MI. All multiva-
riate Cox models were adjusted for the Global Registry of Acute Coronary 
Events (GRACE) risk score, which is a validated 9 variables prediction 
tool, and left ventricular ejection fraction as assessed by echocardiography 
<3 days after admission. The additional prognostic information of HBG 
was tested by comparing the -2log likelihood of the Cox models with vs 
without HBG (chi²).
Results: In the study population (n=3358), both admission glycemia as 
a continuous variable and HBG were univariately associated with increased 
mortality (HR(95%CI: 1.06(1.05-1.07) and 2.67(2.17-3.29), respectively). The 
addition of either admission glycemia as a continuous variable (HR(95%CI): 
1.04(1.01-1.06) or of HBG (HR(95%CI): 1.61(1.28-2.03)) signi¿ cantly 
improved the risk prediction in the multivariate model (chi²: p<0.001). 
However, in diabetic patients (n=756), HBG failed to independently predict 
mortality (HR(95%CI):1.17(0.80-1.71)). In contrast, in non diabetic patients 
(n=2592), HBG remained an independent predictor of death (HR(95%CI): 
1.93(1.39-2.67)) and added incremental prognostic value in the model over 
the GRACE risk score and LVEF (chi²: p<0.001).
Conclusion:  High blood glucose on admission provides incremental pro-
gnostic information over established risk score and LVEF, in particular in non 
diabetic patients. Admission glycemia is not an independent predictive marker 
in diabetic patients.
Conclusion: This work demonstrates speci¿ c pro¿ les of dental status 
according to age. In younger patients, the dental status was poor, but no rela-
tionship with CRP was shown. Further studies are needed to include a more 
speci¿ c assessment of coronary lesions and their evolution in this context of 
poor dental health.
Tertile 1 Tertile 2 Tertile 3 p
N 66 66 65
Mean age, y 47.7±0.4 59.5±0.3 72.5±0.4 <0.001
Men 83% 89% 75% 0.104
CRP > 3 mg/L, 52% 41% 54% 0.205
Current smoker 72% 63% 47% 0.017
Periondontal status
Presence of caries 50% 28% 45% 0.037
Presence of inÀ ammation 64% 71% 67% 0.731
Teeth lost 8±8 10±8 15±8 0.019
Alteration of chewing 24% 34% 67% <0.001
Bone Loss 55% 71% 86% 0.001
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